GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (XSWX:ATLNE) » Definitions » Total Inventories

Actelion (XSWX:ATLNE) Total Inventories : CHF133 Mil (As of Mar. 2017)


View and export this data going back to . Start your Free Trial

What is Actelion Total Inventories?

Actelion's total inventories for the quarter that ended in Mar. 2017 was CHF133 Mil. Actelion's average total inventories from the quarter that ended in Dec. 2016 to the quarter that ended in Mar. 2017 was CHF134 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Actelion's Net-Net Working Capital per share for the quarter that ended in Mar. 2017 was CHF0.89.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Actelion's Days Inventory for the three months ended in Mar. 2017 was 187.22.

Inventory Turnover measures how fast the company turns over its inventory within a year. Actelion's Inventory Turnover for the quarter that ended in Mar. 2017 was 0.49.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Actelion's Inventory-to-Revenue for the quarter that ended in Mar. 2017 was 0.21.


Actelion Total Inventories Historical Data

The historical data trend for Actelion's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Total Inventories Chart

Actelion Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.39 53.24 60.88 62.11 135.82

Actelion Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.57 121.03 120.33 135.82 132.57

Actelion Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Actelion  (XSWX:ATLNE) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Actelion's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2017 is

Net-Net Working Capital Per Share (Q: Mar. 2017 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(759.776+0.75 * 0+0.5 * 132.571-727.47
-0--4.66)/115.457
=0.89

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Actelion's Days Inventory for the three months ended in Mar. 2017 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2017 )/Cost of Goods Sold (Q: Mar. 2017 )*Days in Period
=134.1955/65.407*365 / 4
=187.22

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Actelion's Inventory Turnover for the quarter that ended in Mar. 2017 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2017 ) / Average Total Inventories (Q: Mar. 2017 )
=65.407 / 134.1955
=0.49

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Actelion's Inventory to Revenue for the quarter that ended in Mar. 2017 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2017 ) / Revenue (Q: Mar. 2017 )
=134.1955 / 646.253
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Actelion Total Inventories Related Terms

Thank you for viewing the detailed overview of Actelion's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Actelion (XSWX:ATLNE) Business Description

Traded in Other Exchanges
N/A
Address
Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (XSWX:ATLNE) Headlines

No Headlines